Home > Boards > US OTC > Medical - Drugs >

Elite Pharmaceuticals (ELTP)

Add ELTP Price Alert      Hide Sticky   Hide Intro
Moderator: Drugdoctor, dr_lowenstein, NASDAQ2020, IB_, namtae, Chasing
Search This Board: 
Last Post: 2/22/2018 9:54:24 AM - Followers: 834 - Board type: Free - Posts Today: 10

Elite Pharmaceuticals, Inc. (ELTP)

About Elite Pharmaceuticals
Elite Pharmaceuticals is a specialty pharmaceutical company specializing in niche generics and committed to the development of abuse-deterrent opioids to help curb diversion, misuse and abuse.  Elite has a pipeline of opioid abuse-deterrent products under development utilizing the company’s proprietary pharmacological abuse-deterrent technology. 
Located in Northvale, New Jersey, Elite operates a 55,000 square foot campus under Current Good Manufacturing Practice (“cGMP”) and is a United States Drug Enforcement Agency (“DEA”) registered facility for research, development, manufacturing and packaging of pharmaceutical products.
More information including Elite’s proprietary Abuse Resistant Technology can be found at

About Elite's Abuse Deterrent Technology

Elite's abuse deterrent products utilize the Company's proprietary pharmacological abuse deterrent technology. Elite's abuse deterrent technology is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist. Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed, the opioid antagonist, naltrexone, is designed to release. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers.
Elite continues to expands the intellectual property for the Company's opioid abuse deterrent technology. Elite now has four US patents, one European patent, and two Canadian patents issued in this area with additional patents pending in the U.S., Canada and Europe.
Products & Pipeline
Elite’s principle product is SequestOx, an immediate-release oxycodone with sequestered naltrexone abuse-deterrent opioid product for the management of moderate to severe acute pain. Additional products include bariatric, cardiovascular, antihistamine, skeletal muscle relaxants, antipsychotic, tricyclic antidepressant, along with a number of approved products pending manufacturing site transfer.
Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy's Laboratories and Valeant Pharmaceuticals International. Additional information regarding Elite’s wholly owned products, partnerships, and contract manufacturing can be found at
The list of pipeline products can be found at
Nasrat Hakim, Chairman, President & Chief Executive Officer
Nasrat Hakim joined Elite in August 2013 as Director, President and Chief Executive Officer. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He brings with him proven management experience, in-depth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. Prior to his leading Elite, from 2004 to 2013, Mr. Hakim was employed by Actavis, Watson and Alpharma in various senior management positions. Most recently, Mr. Hakim served as International Vice President of Quality Assurance at Actavis, overseeing 25 sites with more than 3,000 employees under his leadership.  Mr. Hakim also served as Corporate Vice President of Technical Services, Quality and Regulatory Compliance for Actavis U.S., Global Vice President, Quality and Regulatory Compliance for Alpharma, as well as Executive Director of Quality Unit at TheraTech, overseeing manufacturing and research and development. In 2009, Mr. Hakim founded Mikah Pharma, LLC, a virtual, fully functional pharmaceutical company. 

Mr. Hakim’s career started in Medical Laboratory Technology from the Academy of Health and Sciences in the U.S. Army based in San Antonio, TX, followed by Graduate Certification in Regulatory Affairs (RAC) from California State University at Sacramento, Sacramento, CA; Bachelor in Chemistry/Bio-Chemistry and Masters of Science in Chemistry from California State University at Sacramento, Sacramento, CA; and a Masters in Law with Graduate Certification in U.S. Taxation from St. Thomas University, School of Law, Miami, FL.

Investor Relations and Corporate Inquiries

Dianne Will
Vice President of Investor Relations and Corporate Affairs
Telephone: 518-398-6222

Corporate Headquarters
165 Ludlow Avenue
Northvale, New Jersey 07647
Phone: 201-750-2646
Fax: 201-750-2755


Miscellaneous Links:
Elite Pharmaceuticals News
SEC Filings

FDA website

Clinical Trials.Gov
Yahoo Finance
Seeking Alpha

ELTP Daily Chart

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ELTP News: Current Report Filing (8-k) 02/09/2018 05:03:16 PM
ELTP News: Quarterly Report (10-q) 02/09/2018 04:44:24 PM
ELTP News: Current Report Filing (8-k) 02/08/2018 01:39:57 PM
ELTP News: Current Report Filing (8-k) 01/31/2018 07:38:14 AM
ELTP News: Current Report Filing (8-k) 01/10/2018 04:46:51 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#283248  Sticky Note ELTP Conference Call Information this Friday, February 12 conix 02/08/18 03:51:55 PM
#279326  Sticky Note The last close out letter from the FDA toofun 12/08/17 11:57:54 AM
#274770  Sticky Note memorable "calls" for elite pharma: dr_lowenstein 10/24/17 04:09:11 PM
#271038  Sticky Note Elite Pharma at Pain Week 2017 NASDAQ2020 09/17/17 04:03:01 PM
#234937  Sticky Note THIS IS WHAT YOU NEED TO KNOW BEFORE Couch 11/30/16 03:04:07 PM
#185967  Sticky Note The only topic here is ELTP. IH Dan (Retired) 02/23/16 09:32:46 PM
#284394   Could be tomorrow, one never knows with the Fda newguy11 02/22/18 09:54:24 AM
#284393   NAMMY, i hate to have to agree with SCHH 02/22/18 09:43:47 AM
#284392   I can tell you which ones HAVENT been first namtae 02/22/18 09:00:18 AM
#284391   Which one will be first ? Investintin 02/22/18 08:51:24 AM
#284390   Which one will be first ? NASDAQ2020 02/22/18 08:17:33 AM
#284389   Aren't we due for an approval of a Investintin 02/22/18 08:09:53 AM
#284388   Aren't we due for an approval of a senderos 02/22/18 07:48:08 AM
#284387   Hi Nas, Investintin 02/22/18 07:27:38 AM
#284386   Still a .10 cent stock. GL. E92M 02/22/18 07:09:05 AM
#284384   And just wait until Elite gets their better Jimmy Joe 02/21/18 11:47:45 PM
#284383   MORE BS like the PR due out this stockboy 02/21/18 11:38:15 PM
#284382   Say where was that BLOCK BUSTER PR we stockboy 02/21/18 11:37:07 PM
#284381   How many years away, and millions of shares stockboy 02/21/18 11:35:49 PM
#284380   That's still not out of the question, just stockboy 02/21/18 11:34:52 PM
#284379   He is "DOING SOMETHING" to just pro long stockboy 02/21/18 11:30:14 PM
#284378   Projected Revenues SequestOx™ for Emergency Room Doctors and NASDAQ2020 02/21/18 09:14:32 PM
#284376   Still BS Investintin 02/21/18 05:53:14 PM
#284375   Still BS YJ4LIFE 02/21/18 05:50:28 PM
#284373   Hahahaha Both IMS and Evaluate are paid platforms... These Investintin 02/21/18 05:17:50 PM
#284372   YJ4LIFE. . .thanks. Felt good getting that off rrr2003 02/21/18 05:09:50 PM
#284371   You are absolutely correct. YJ4LIFE 02/21/18 05:03:42 PM
#284370   To maximize the tax write off. Lol jour_trader 02/21/18 04:45:41 PM
#284369   Well, it could be because the longs know rrr2003 02/21/18 04:44:18 PM
#284368   I agree 62bluejay 02/21/18 04:34:56 PM
#284367   link? NO link = BS YJ4LIFE 02/21/18 03:57:50 PM
#284366   Wondering why one stays long Elite knowing this namtae 02/21/18 03:52:34 PM
#284365   That’s mostly a fair assessment. Absolutely agree on mrwrn2010 02/21/18 03:51:43 PM
#284363  Restored You’re literally responding to a post showing SequestOx mrwrn2010 02/21/18 03:40:55 PM
#284362   Yeah I heard .02 and bankruptcy was coming mrwrn2010 02/21/18 03:39:28 PM
#284361   I completely agree with the dodgy Mikah purchases jour_trader 02/21/18 02:16:14 PM
#284360   still trying to get filled at .09, inrags86 02/21/18 02:07:08 PM
#284359   Investintin, we are all anticipating new happenings, snupoled 02/21/18 01:46:16 PM
#284358   Prior to their little pilot study there was Jimmy Joe 02/21/18 01:22:03 PM
#284356   I believe Nasrat commented last year that he jour_trader 02/21/18 12:31:14 PM
#284355   No need to prove anything as the fda dr_lowenstein 02/21/18 12:30:18 PM
#284354   the seven year issue that was long ago WeeZuhl 02/21/18 12:25:38 PM
#284353   the seven year issue that was long ago Investintin 02/21/18 12:16:37 PM
#284352   It's coming.You are right, all those successful approved Jimmy Joe 02/21/18 12:07:50 PM
#284351   the seven year issue that was long ago dr_lowenstein 02/21/18 11:41:09 AM
#284350   Well thank you for the welcoming message Investintin 02/21/18 10:54:04 AM
#284349   Well he can only handle 7 CRL’s at stockboy 02/21/18 10:45:50 AM
#284348   Any discussion about product competition is merely a no2koolaid 02/21/18 10:29:45 AM
#284347   Investtintin, welcome to our board guy, snupoled 02/21/18 10:27:51 AM
#284346   Last I checked Nas working on 7 ADF Investintin 02/21/18 09:55:06 AM
#284344   Sorry but Elite has been making PRs about namtae 02/21/18 09:49:22 AM
#284343   So why isn’t UN-Elite doing anything with SequesTOX? stockboy 02/21/18 09:46:21 AM
#284342   Elite new Unique ADF blows the comparator out NASDAQ2020 02/21/18 09:43:49 AM
#284341   Actually you only heard about SequestOx in 2016, Gman24 02/21/18 09:40:28 AM
#284340   Last I checked Nas working on 7 ADF NASDAQ2020 02/21/18 09:32:28 AM
#284339   Heard the same BS in 2016 & 2017 namtae 02/21/18 09:32:24 AM